KMT2A and acute myeloid leukemia: Inactivation of DOT1L significantly suppressed the HOXA9 and MEIS1 genes associated with MLL translocation and leukemogenesis, leading to decreased proliferation, increased differentiation, and apoptosis of MLL–AF9 cells, indicating its potential for AML therapy [37,65,97,99].